Results 51 to 60 of about 27,411 (201)
British Journal of Clinical Pharmacology, EarlyView.Abstract Cyclizine is a long‐established, short‐acting drug, registered for preventing motion sickness, post‐operative nausea and vomiting (PONV) and ‘vomiting of known cause’. The latter is not defined but may include pregnancy and patients receiving palliative care, historically accepted without large, controlled trials.
Gareth J. Sanger, Paul L. R. Andrews
wiley +1 more source
Octreotide Therapy in Asparaginase-Associated Pancreatitis in Childhood Acute Lymphoblastic Leukemia [PDF]
, 2010 [[abstract]]Little is known about octreotide therapy in asparaginase-associated pancreatitis (AAP) in children. Of the 59 children with acute lymphoblastic leukemia (ALL) receiving E. Coli L-asparaginase, 5 patients (8.5%) developed AAP.
Wu, SF (Wu, Shu-Fen); Chen, AC (Chen, An-Chyi); Peng, CT (Peng, Ching-Tien); Wu, KH (Wu, Kang-Hsi)
core
Octreotide Uptake in Parathyroid Adenoma
, 2012 The patient with a history of bone pain and muscle weakness, was thought to have oncogenic osteomalacia as a result of biochemical investigations and directed to Nuclear Medicine Department for a whole-body bone scintigraphy and In-111-octreotide ...
Karacavus, Seyhan +6 more
core +1 more source
Case report: Octreotide Associated Hyperkalemia [PDF]
, 2022 78-year-old female with past medical history of acromegaly status post pituitary adenoma status post resection presents to the emergency department with abdominal pain.
Schuitema, Henry +5 more
core +1 more source
Elevated miR-16-5p induces somatostatin receptor 2 expression in neuroendocrine tumor cells.
PLoS ONE, 2020 Somatostatin analogs, which are used to treat neuroendocrine tumors, inhibit hormone secretion or promote tumor shrinkage; however, their efficacy varies between patients, possibly because of differential expression of somatostatin receptors (SSTRs) in ...
HanHee Jo +8 more
doaj +1 more source
BMC Cancer, 2020 Background This analysis aims to evaluate health-related quality of life (HrQoL) (primary outcome for this analysis), nausea and vomiting, and pain in patients with inoperable malignant bowel obstruction (IMBO) due to cancer or its treatments randomised ...
Nikki McCaffrey +11 more
doaj +1 more source
Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton +3 more
wiley +1 more source
, 2015 Octreotide, a disulfide-cyclized eight amino acids long analogue of somatostatin, has been used to treat the symptoms associated with metastatic carcinoid tumors (flushing and diarrhea), and vasoactive intestinal peptide secreting adenomas (watery ...
Yuan, Qipeng +11 more
core +1 more source
Molecular theranostics: principles, challenges and controversies
Journal of Medical Radiation Sciences, Volume 72, Issue 1, Page 156-164, March 2025.Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
Graves' dermopathy: does octreotide scintigraphy predict the response to octreotide treatment?
, 1996 We report on three patients with severe Graves' dermopathy who were treated with octreotide despite a negative octreotide scintigraphy. One patient showed a complete recovery while two others had a partial response.
van der Pijl, J. W. +3 more
core +1 more source